<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01563705</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A00615-34</org_study_id>
    <nct_id>NCT01563705</nct_id>
  </id_info>
  <brief_title>Prospective Follow-up of Patients With Glycogen Storage Disease Type III</brief_title>
  <acronym>PRO GSDIII</acronym>
  <official_title>Prospective Follow-up of Patients With Glycogen Storage Disease Type III</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to improve knowledge of natural history and methods of monitoring
      the evolution of Glycogen storage disease type III regarding the muscle and to study the
      prospective approach of large series of patients, and using the same protocol for the follow
      up of the children and adults.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee flexion and extension strength</measure>
    <time_frame>at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee flexion and extension strength</measure>
    <time_frame>2 years after baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee flexion and extension strength</measure>
    <time_frame>4 years after baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to perform each motor function test</measure>
    <time_frame>at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to perform each motor function test</measure>
    <time_frame>2 years after baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to perform each motor function test</measure>
    <time_frame>4 years after baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gait speed measured during the 6 minutes walk test</measure>
    <time_frame>at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gait speed measured during the 6 minutes walk test</measure>
    <time_frame>2 years after baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gait speed measured during the 6 minutes walk test</measure>
    <time_frame>4 years after baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accelerometric variables measured for the 6 minutes walk test</measure>
    <time_frame>At baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accelerometric variables measured for the 6 minutes walk test</measure>
    <time_frame>2 years after baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accelerometric variables measured for the 6 minutes walk test</measure>
    <time_frame>4 years after baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NMR variables measured during each specific NMR sequence</measure>
    <time_frame>at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NMR variables measured during each specific NMR sequence</measure>
    <time_frame>2 years after baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NMR variables measured during each specific NMR sequence</measure>
    <time_frame>4 years after baseline</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Neuromuscular Disorders</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Different motor function tests</intervention_name>
    <description>Time to rise from a chair, time to go from lying to sitting, time to go from lying to standing, time to cover 10 meters, time to climb 4 steps</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Manual dexterity assessment</intervention_name>
    <description>Purdue pegboard test</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with a debranching enzyme deficiency confirmed by enzymatic analysis
             (debranching enzyme deficiency).

          -  Written consent

          -  Age: at least 10 years

          -  Affiliated with a social security system

        Exclusion Criteria:

          -  Pregnant and lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pascal Laforet, MD</last_name>
    <phone>00 331 42 16 37 75</phone>
    <email>pascal.laforet@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre Carlier, MD, PhD</last_name>
    <email>p.carlier@institut-myologie.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Myologie</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Laforet, MD</last_name>
      <phone>00 331 42 16 37 75</phone>
      <email>pascal.laforet@psl.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre Carlier, MD, PhD</last_name>
      <email>p.carlier@institut-myologie.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2012</study_first_submitted>
  <study_first_submitted_qc>March 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2012</study_first_posted>
  <last_update_submitted>December 19, 2012</last_update_submitted>
  <last_update_submitted_qc>December 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular Disorders</keyword>
  <keyword>GSD III</keyword>
  <keyword>glycogen storage disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Glycogen Storage Disease Type III</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

